Is it Time to Sell/Buy Crinetics Pharmaceuticals Inc. (CRNX) Stock After Recent Trade?

Is it Time to Sell/Buy Crinetics Pharmaceuticals Inc. (CRNX) Stock After Recent Trade?

Crinetics Pharmaceuticals Inc. (CRNX) share price soared 11.07% with the closing price of $17.05 on Friday. Crinetics Pharmaceuticals Inc. stock has an exchanging volume of 0.14 million shares, which is high, contrasted with its 3-months average volume of 100.41K shares. Its market capitalization has now reached to $592.32M. Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism on September 21, 2020 news published at Yahoo. CRNX Past…

Read More